Medical Oncologist
CION Cancer Clinics
Systemic treatment for liver cancer when hepatitis B is still active | CION Cancer Clinics
Active hepatitis B does not usually stop you having immunotherapy or tablets for liver cancer. It does mean an antiviral tablet must be running before treatment starts and must continue throughout. This page explains why the virus matters, how the team weighs the cancer, the liver and the virus together, and who this approach does not suit. At CION Cancer Clinics, a multidisciplinary tumour board weighs your liver function and your scans before recommending any treatment.
NG
Medically reviewed by Dr. Naresh GunduConsultant Medical Oncologist · MBBS, DNB (Internal Medicine), DM (Medical Oncology, AIIMS) · last reviewed October 2026, next review due October 2027
17+specialists on panel
15,000+patients treated
35+centres across Telangana & AP
4.8★ / 800+Google rating
On this page
- Can I have liver cancer treatment while hepatitis B is still active?
- What does the team look at before choosing a treatment?
- How is hepatitis B managed alongside cancer treatment?
- Does the type of treatment change the hepatitis B plan?
- Who is systemic treatment with active hepatitis B not suitable for?
- What this page cannot tell you
- Common questions about hepatitis B and liver cancer treatment
The short answer
Can I have liver cancer treatment while hepatitis B is still active?
Yes, in most cases. Active hepatitis B does not on its own rule out immunotherapy, tablets or other systemic treatment for liver cancer. What it does mean is that antiviral medicine has to be running before the cancer treatment starts, and has to keep running all the way through.
This page is for people with hepatocellular carcinoma (HCC, the cancer that starts in the liver's own cells) whose hepatitis B blood tests still show the virus is active. If your cancer started somewhere else and spread to the liver, the hepatitis B advice is similar, but the treatment choices are different, so ask your oncologist which page applies to you.
Why the virus matters during cancer treatment
Hepatitis B is controlled, not cleared. Even when it seems quiet, the virus stays inside liver cells. Cancer treatment can change how the immune system holds it in check. When that balance shifts, the virus can wake up and multiply. This is called reactivation, and it can inflame the liver badly enough to stop cancer treatment or to harm a liver already weakened by cirrhosis (scarring).
The good news is that this risk is well known and largely preventable. Modern antiviral tablets keep the virus down, and the plan is built around them from the first day.
Never stop a hepatitis B tablet on your own, even if a report looks good. Stopping can trigger a flare.Before anything starts
What does the team look at before choosing a treatment?
Three things are weighed together: the cancer, the liver and the virus. A choice that suits one and ignores the others is not a safe plan.
The cancer
How large it is, how many tumours there are, whether it has reached the portal vein (the main vein bringing blood into the liver) and whether it has spread beyond the liver. These decide whether systemic treatment is the right tool at all.
The liver
How well the liver still works, measured by bilirubin, albumin, INR and the Child-Pugh score, a simple grade of liver strength. A liver with little reserve tolerates any flare poorly, so this weighs heavily in the choice.
Often checked
- Bilirubin and albumin
- INR, a clotting test
- Fluid in the abdomen or past confusion
The virus
Whether HBsAg is positive, how much virus is in the blood (the viral load), and whether you are already on an antiviral. A test for hepatitis D is also worth asking about, because it makes hepatitis B behave more aggressively.
You
How active you are day to day, other illnesses such as diabetes or kidney disease, and what matters most to you. Kidney function also guides which antiviral tablet is chosen.
Not sure whether this applies to you?
Ask an oncologistStep by step
How is hepatitis B managed alongside cancer treatment?
Blood tests at diagnosis
Everyone diagnosed with liver cancer is tested for hepatitis B and C, even if they were tested before. The results shape the whole plan. Our page on hepatitis testing at diagnosis explains why.
Antiviral treatment starts first
A hepatologist or physician starts an antiviral tablet such as entecavir or tenofovir if you are not already on one. Ideally the virus is brought down before cancer treatment begins. The exact timing is a decision for your doctors.
The tumour board agrees the plan
Medical oncologists, surgeons and radiation doctors review the scans with the liver and viral results in front of them. They agree a treatment that fits all three.
Regular checks during treatment
Liver tests are repeated before each treatment, and the viral load is checked at intervals. A rise is picked up early, while it can still be managed.
Antivirals continue afterwards
The antiviral tablet usually continues long after cancer treatment ends. Only the doctor managing your hepatitis B decides if and when it can ever stop.
Side by side
Does the type of treatment change the hepatitis B plan?
Treatment
What it means for hepatitis B
Immunotherapy combinations, such as atezolizumab plus bevacizumab
Used in people with hepatitis B when the virus is controlled on antivirals, with liver tests watched closely
Tablets such as sorafenib or lenvatinib
Antiviral cover continues in the same way, and liver tests are still checked regularly
Ordinary chemotherapy
Suppresses immunity more broadly, so reactivation is a recognised risk and antiviral cover is essential
TACE or other liver-directed treatment
Can also stir up the virus, so the same antiviral rules apply
Leave a number, we will call you
One field. No form to fill in, and no charge for the call.
Being honest
Who is systemic treatment with active hepatitis B not suitable for?
For some people, the safest choice is to hold back or to choose a gentler path. This is not a judgement about how the infection was caught. It is about what the liver can take.
When the liver is already failing
If the liver is badly scarred and struggling, with deep jaundice, fluid that keeps coming back or repeated confusion, a viral flare or a drug side effect could tip it over. Here the team may suggest focusing on the liver itself and on comfort. Our page on treatment with Child-Pugh B liver function explains the middle ground.
When the virus cannot be brought under control
Rarely, the virus stays high despite treatment, or a flare is already under way. Cancer treatment may then wait until the liver settles.
When someone cannot keep up the checks
The plan only works if antiviral tablets are taken every day and blood tests happen on time. If travel from a district or cost makes that hard, say so early. The team can often arrange tests closer to home.
Bevacizumab also needs an endoscopy first, to check for swollen veins in the food pipe that could bleed.Being straight with you
What this page cannot tell you
It cannot tell you which antiviral tablet you need, whether your viral load is low enough to begin, or which cancer treatment suits your scan. Those answers depend on your reports, read together, by people who know your liver.
Who decides what
The antiviral decision belongs to a hepatologist or physician. CION coordinates hepatology care through partner specialists, while CION's medical oncologists plan and give the immunotherapy, targeted therapy or chemotherapy. Both work from the same reports.
What about the family?
Hepatitis B often passes quietly within families, from mother to baby at birth or between young children. Nobody is to blame for that. If you have not yet done so, it helps to have close family tested and vaccinated, as our page on testing the family for hepatitis B describes.
If you are unsure whether your hepatitis B is active, bring your latest reports to a consultation and ask.Questions we are asked
Common questions about hepatitis B and liver cancer treatment
Does active hepatitis B stop me from having immunotherapy?
Not usually. People with hepatitis B can have immunotherapy for liver cancer, provided the virus is controlled with an antiviral tablet and the liver is strong enough. Your doctors will check the viral load and liver tests first. More detail is on our page on immunotherapy with hepatitis B or cirrhosis.
What is hepatitis B reactivation?
It is when a virus that was quiet starts multiplying again, usually because treatment has weakened the immune system's hold on it. It can cause liver inflammation and, at worst, liver failure. Antiviral tablets taken before and during treatment prevent most cases.
I was told I am an inactive carrier. Do I still need antivirals?
Often yes, for the length of cancer treatment and for a while after it. A quiet virus can still reactivate when treatment changes the immune system. Your hepatologist will decide based on your blood tests and the treatment planned.
Can I stop my hepatitis B tablet once cancer treatment ends?
Do not stop it yourself. Stopping can cause a sudden flare, which is dangerous in a liver that has cirrhosis or cancer. Many people with liver cancer stay on the tablet for life. Only the doctor managing your hepatitis B should change it.
Will the antiviral tablet interfere with my cancer medicine?
Entecavir and tenofovir are generally used alongside cancer treatment without trouble. Tell every doctor about every medicine you take, including tonics and herbal products, so the full list can be checked together.
What signs of a flare should I watch for?
Yellow eyes or skin, very dark urine, unusual tiredness, loss of appetite, or a swelling abdomen. Some flares cause no symptoms and show only on blood tests, which is why the checks matter. Report new jaundice to your team the same day.
Does having hepatitis B make the cancer harder to treat?
It adds a layer of planning rather than closing doors. Treatment choices depend more on the size and spread of the cancer and on liver function. When the virus is controlled, people with hepatitis B are offered the same main options as others.
Should my family be tested?
Yes, it is a good idea. Close relatives and people you live with can be tested with a simple blood test, and those who are not protected can be vaccinated. This protects them without blaming anyone. Call the CION helpline if you need help arranging it.
Your Specialists
Meet CION's liver cancer specialists. Bring your scan reports and liver blood tests.
Our medical and surgical oncologists plan liver cancer care together, weighing the tumour and how well your liver works before choosing surgery, a liver-directed procedure or medicines.
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Sources
- American Cancer Society — Immunotherapy for Liver Cancer
- NIDDK — Hepatitis B - NIDDK
- World Health Organization — Hepatitis B
- AASLD — Practice Guidelines
This page is general information, not a prescription. Do not change or stop any treatment based on what you read here. If anything is worrying you, contact your own treating team — or call our helpline and we will help you reach the right specialist.
Keep reading
Related pages
Hepatitis B reactivation during cancer treatmentWhat reactivation is and how it is preventedAtezolizumab plus bevacizumab for liver cancerThe usual first choice, explainedStopping hepatitis B medicine: why it is riskyWhy the antiviral tablet must not be stoppedSystemic treatment with Child-Pugh B liver functionWhen the liver itself is weaker
Talk to us
Worried hepatitis B will hold up treatment?
Bring your hepatitis B and liver reports, and a CION medical oncologist will explain how they shape your treatment options. One helpline serves every CION centre.